Scarica l'app Stockscreener
134.44
0.25%
0.33
Dopo l'orario di chiusura:
134.26
-0.18
-0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
India Medical Nutrition Market Future Trends and Scope Analysis - openPR.com
Abbott, MSD Forge Diabetes‑Drug Pact For Wider Indian Reach - BW Healthcare World
Abbott Labs stock price target maintained at $140 by Oppenheimer - Investing.com India
Leerink Partners Begins Coverage on ABT - Insider Monkey
10 Best Dividend Stocks to Buy for Dependable Dividend Growth - Insider Monkey
Who Rules Homecare Clinical Nutrition Market? Abbott, Danone, - openPR.com
Health Canada approves Abbott’s i-STAT TBI test for suspected concussions - Medical Device Network
Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management - Insider Monkey
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent
Abbott (ABT) Stock Dips While Market Gains: Key Facts - Nasdaq
Eaton makes a move outside of the data center — plus, what's new with Abbott Labs - CNBC
Abbott Wins Dismissal of Whistleblower’s Medicare Fraud Suit - Bloomberg Law News
Abbott Declares 406th Consecutive Quarterly Dividend - marketscreener.com
Abbott Laboratories' Whole Blood Concussion Test Approved by Health Canada - marketscreener.com
Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions - Barchart.com
Blood Screening Market Outlook | Key Players: Abbott Laboratories, Roche, Grifols, BioMérieux - openPR.com
Deep Venous Disease Treatment Market Key Players Analysis - openPR.com
1 Unpopular Stock that Should Get More Attention and 2 to Avoid - FinancialContent
Jim Cramer Calls Abbott “Really Excellent” - Insider Monkey
Electrophysiology Devices Market Share Leaders: Abbott, Acutus Medical, and Biosense Webster - openPR.com
Abbott Laboratories (ABT) Maintains Quarterly Dividend of $0.59 - GuruFocus
Abbott Declares 406Th Consecutive Quarterly Dividend, Payable on August 15, 2025 - marketscreener.com
Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks - Investing.com Nigeria
Abbott Laboratories Keeps Quarterly Dividend at $0.59 per Share, Payable August 15 to Shareholders as of July 15 - marketscreener.com
Clinical Immunochemistry Analyzers Market projected reach USD 6.9 billion by 2034, growing at a CAGR of 4.4% | Exactitude Consultancy - GlobeNewswire Inc.
Abbott Laboratories Stock Sees RS Rating Rise To 82 - Investor's Business Daily
Stocks To Watch: Abbott Laboratories Sees RS Rating Rise To 82 - MSN
Abbott and Medtronic best positioned manufacturers in US neurology market - PharmaLive
Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions - simplywall.st
Tandem, Abbott team on insulin delivery with glucose-ketone sensor - MedTech Dive
Tandem Diabetes (TNDM) Partners with Abbott for Innovative Diabe - GuruFocus
Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor - Seeking Alpha
Abbott (ABT) Partners with Tandem Diabetes for Advanced Diabetes Management Solutions | ABT Stock News - GuruFocus
3 Low-Volatility Stocks in Hot Water - FinancialContent
Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector? - MSN
Abbott Laboratories (ABT) Stock Dips Slightly on NYSE, Long-Term Gains Remain Solid - Daily Chhattisgarh News
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Thousands of lawsuits over baby formula should stay where filed, court says - Reuters
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Test Strip Market Is Booming So Rapidly 2025-2032 -Abbott - openPR.com
Abbott Announces FDA Approval Of Tendyne Transcatheter Mitral Valve Replacement System - insights.citeline.com
Abbott Laboratories Stock: Is ABT Outperforming The Health Care Sector? - Barchart.com
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $153 From $147, Maintains Buy Rating - marketscreener.com
There's Been No Shortage Of Growth Recently For Abbott Laboratories' (NYSE:ABT) Returns On Capital - Yahoo Finance
Abbott Tendyne TMVR secures FDA clearance - BioWorld MedTech
Cardiac Marker Analyzer Market Is Booming WorldwideAbbott, Roche Diagnostics - openPR.com
Abbott Labs (ABT) Stock Ticks Lower: Gauging the Pulse and Future Price Points - Daily Chhattisgarh News
0.67%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):